These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 14722676)
1. Radioiodine-131 in differentiated thyroid cancer: a retrospective analysis of an uptake-related ablation strategy. Verkooijen RB; Stokkel MP; Smit JW; Pauwels EK Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):499-506. PubMed ID: 14722676 [TBL] [Abstract][Full Text] [Related]
2. Postsurgical thyroid remnant estimation by (⁹⁹m) Tc-pertechnetate scintigraphy predicts radioiodine ablation effectiveness in patients with differentiated thyroid carcinoma. Giovanella L; Suriano S; Ricci R; Ceriani L; Anton Verburg F Head Neck; 2011 Apr; 33(4):552-6. PubMed ID: 20824809 [TBL] [Abstract][Full Text] [Related]
3. Low versus high radioiodine dose in postoperative ablation of residual thyroid tissue in patients with differentiated thyroid carcinoma: a large randomized clinical trial. Fallahi B; Beiki D; Takavar A; Fard-Esfahani A; Gilani KA; Saghari M; Eftekhari M Nucl Med Commun; 2012 Mar; 33(3):275-82. PubMed ID: 22124360 [TBL] [Abstract][Full Text] [Related]
4. Short-term effectiveness of low-dose radioiodune ablative treatment of thyroid remnants after thyroidectomy for differentiated thyroid cancer. Vermiglio F; Violi MA; Finocchiaro MD; Baldari S; Castagna MG; Moleti M; Mattina F; Pio Lo Presti V; Bonanno N; Trimarchi F Thyroid; 1999 Apr; 9(4):387-91. PubMed ID: 10319946 [TBL] [Abstract][Full Text] [Related]
5. Influence of diagnostic and therapeutic doses on thyroid remnant ablation rates. Karam M; Gianoukakis A; Feustel PJ; Cheema A; Postal ES; Cooper JA Nucl Med Commun; 2003 May; 24(5):489-95. PubMed ID: 12717064 [TBL] [Abstract][Full Text] [Related]
6. Comparison of 800 and 3700 MBq iodine-131 for the postoperative ablation of thyroid remnant in patients with low-risk differentiated thyroid cancer. Caglar M; Bozkurt FM; Akca CK; Vargol SE; Bayraktar M; Ugur O; Karaağaoğlu E Nucl Med Commun; 2012 Mar; 33(3):268-74. PubMed ID: 22205241 [TBL] [Abstract][Full Text] [Related]
7. Prognostic value of an increase in the serum thyroglobulin level at the time of the first ablative radioiodine treatment in patients with differentiated thyroid cancer. Bernier MO; Morel O; Rodien P; Muratet JP; Giraud P; Rohmer V; Jeanguillaume C; Bigorgne JC; Jallet P Eur J Nucl Med Mol Imaging; 2005 Dec; 32(12):1418-21. PubMed ID: 16133388 [TBL] [Abstract][Full Text] [Related]
8. Radioiodine lobar ablation as an alternative to completion thyroidectomy in patients with differentiated thyroid cancer. Bal CS; Kumar A; Pant GS Nucl Med Commun; 2003 Feb; 24(2):203-8. PubMed ID: 12548045 [TBL] [Abstract][Full Text] [Related]
9. Radioiodine remnant ablation in low-risk differentiated thyroid cancer. Saengsuda Y J Med Assoc Thai; 2013 May; 96(5):614-24. PubMed ID: 23745318 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of low and high 131I doses for thyroid remnant ablation in patients with differentiated thyroid carcinoma based on post-operative cervical uptake. Rosário PW; Reis JS; Barroso AL; Rezende LL; Padrão EL; Fagundes TA Nucl Med Commun; 2004 Nov; 25(11):1077-81. PubMed ID: 15577584 [TBL] [Abstract][Full Text] [Related]
11. Radioiodine ablation of residual tissue in thyroid cancer: relationship between administered activity, neck uptake and outcome. Logue JP; Tsang RW; Brierley JD; Simpson WJ Br J Radiol; 1994 Nov; 67(803):1127-31. PubMed ID: 7820407 [TBL] [Abstract][Full Text] [Related]
12. Is diagnostic iodine-131 scanning with recombinant human TSH useful in the follow-up of differentiated thyroid cancer after thyroid ablation? Mazzaferri EL; Kloos RT J Clin Endocrinol Metab; 2002 Apr; 87(4):1490-8. PubMed ID: 11932270 [TBL] [Abstract][Full Text] [Related]
13. Patients with differentiated thyroid cancer who underwent radioiodine thyroid remnant ablation with low-activity ¹³¹I after either recombinant human TSH or thyroid hormone therapy withdrawal showed the same outcome after a 10-year follow-up. Molinaro E; Giani C; Agate L; Biagini A; Pieruzzi L; Bianchi F; Brozzi F; Ceccarelli C; Viola D; Piaggi P; Vitti P; Pacini F; Elisei R J Clin Endocrinol Metab; 2013 Jul; 98(7):2693-700. PubMed ID: 23626005 [TBL] [Abstract][Full Text] [Related]
14. Predictive value of the preablation serum thyroglobulin level after thyroidectomy is combined with postablation 131I whole body scintigraphy for successful ablation in patients with differentiated thyroid carcinoma. Lee HJ; Rha SY; Jo YS; Kim SM; Ku BJ; Shong M; Kim YK; Ro HK Am J Clin Oncol; 2007 Feb; 30(1):63-8. PubMed ID: 17278897 [TBL] [Abstract][Full Text] [Related]
15. Correlation between cervical uptake and results of postsurgical radioiodine ablation in patients with thyroid carcinoma. Rosário PW; Maia FF; Cardoso LD; Barroso A; Rezende L; Padrão EL; Purisch S Clin Nucl Med; 2004 Jun; 29(6):358-61. PubMed ID: 15166882 [TBL] [Abstract][Full Text] [Related]
16. Prognostic implication of thyroglobulin and quantified whole body scan after initial radioiodine therapy on early prediction of ablation and clinical response for the patients with differentiated thyroid cancer. Lim I; Kim SK; Hwang SS; Kim SW; Chung KW; Kang HS; Lee ES Ann Nucl Med; 2012 Dec; 26(10):777-86. PubMed ID: 22869417 [TBL] [Abstract][Full Text] [Related]
17. Thyroglobulin measurement before rhTSH-aided 131I ablation in detecting metastases from differentiated thyroid carcinoma. Giovanella L; Ceriani L; Suriano S; Ghelfo A; Maffioli M Clin Endocrinol (Oxf); 2008 Oct; 69(4):659-63. PubMed ID: 18363882 [TBL] [Abstract][Full Text] [Related]
18. Hürthle cell carcinoma: a clinicopathological study of thirteen cases. Ozlem Küçük N; Kulak H; Tokmak E; Tar P; Ibiş E; Aras G Nucl Med Commun; 2006 Apr; 27(4):377-9. PubMed ID: 16531925 [TBL] [Abstract][Full Text] [Related]
19. The value of diagnostic whole-body scanning and serum thyroglobulin in the presence of elevated serum thyrotropin during follow-up of anti-thyroglobulin antibody-positive patients with differentiated thyroid carcinoma who appeared to be free of disease after total thyroidectomy and radioactive iodine ablation. Rosario PW; Mineiro Filho AF; Lacerda RX; dos Santos DA; Calsolari MR Thyroid; 2012 Feb; 22(2):113-6. PubMed ID: 22224815 [TBL] [Abstract][Full Text] [Related]
20. Clinical Outcome of Remnant Thyroid Ablation with Low Dose Radioiodine in Korean Patients with Low to Intermediate-risk Thyroid Cancer. Ha S; Oh SW; Kim YK; Koo do H; Jung YH; Yi KH; Chung JK J Korean Med Sci; 2015 Jul; 30(7):876-81. PubMed ID: 26130949 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]